Association of second trimester uterine artery Doppler parameters with maternal hypertension 2-7 years after delivery.

Biomarkers Doppler Hypertension Preeclampsia Pregnancy Vascular ultrasound

Journal

International journal of cardiology. Cardiovascular risk and prevention
ISSN: 2772-4875
Titre abrégé: Int J Cardiol Cardiovasc Risk Prev
Pays: Netherlands
ID NLM: 9918282077306676

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 23 04 2021
revised: 12 07 2021
accepted: 14 07 2021
entrez: 3 2 2022
pubmed: 4 2 2022
medline: 4 2 2022
Statut: epublish

Résumé

Reduced uterine artery compliance is associated with adverse pregnancy outcomes (APOs) and may indicate underlying maternal cardiovascular pathology. We investigated associations between second trimester uterine artery Doppler (UAD) parameters and incident maternal hypertension 2-7 years after delivery. A cohort of 10,038 nulliparous US participants was recruited early in pregnancy. A subgroup of 3739, without baseline hypertension and with complete follow-up visits 2-7 years after delivery, were included in this analysis. We investigated UAD indicators of compliance including: 1) early diastolic notch; 2) resistance index (RI); and 3) pulsatility index (PI). We defined hypertension as systolic blood pressure ≥130 mmHg, diastolic ≥80 mmHg, or antihypertensive medication use. We calculated odds ratios (OR) and 95 % confidence intervals (95%CI) for associations between UAD parameters and hypertension, adjusting for age, obesity, race/ethnicity, insurance, smoking, and APOs. A total of 187 (5 %) participants developed hypertension after the index pregnancy. Presence of early diastolic notch on UAD was not associated with incident hypertension. Increased RI and PI correlated with higher odds of hypertension (RI: adjusted OR 1.15 [95 % CI 1.03-1.30]; PI: adjusted OR 1.03 [95%CI 1.01-1.05] for each 0.1 unit increase). Maximum RI above 0.84 or maximum PI above 2.3 more than doubled the odds of incident hypertension (RI: adjusted OR 2.49, 95%CI 1.45-4.26; PI: adjusted OR 2.36, 95%CI 1.45-3.86). Higher resistance and pulsatility indices measured on second trimester UAD were associated with increased odds of incident hypertension 2-7 years later, and may be biomarkers of higher maternal cardiovascular risk.

Sections du résumé

BACKGROUND BACKGROUND
Reduced uterine artery compliance is associated with adverse pregnancy outcomes (APOs) and may indicate underlying maternal cardiovascular pathology. We investigated associations between second trimester uterine artery Doppler (UAD) parameters and incident maternal hypertension 2-7 years after delivery.
METHODS METHODS
A cohort of 10,038 nulliparous US participants was recruited early in pregnancy. A subgroup of 3739, without baseline hypertension and with complete follow-up visits 2-7 years after delivery, were included in this analysis. We investigated UAD indicators of compliance including: 1) early diastolic notch; 2) resistance index (RI); and 3) pulsatility index (PI). We defined hypertension as systolic blood pressure ≥130 mmHg, diastolic ≥80 mmHg, or antihypertensive medication use. We calculated odds ratios (OR) and 95 % confidence intervals (95%CI) for associations between UAD parameters and hypertension, adjusting for age, obesity, race/ethnicity, insurance, smoking, and APOs.
RESULTS RESULTS
A total of 187 (5 %) participants developed hypertension after the index pregnancy. Presence of early diastolic notch on UAD was not associated with incident hypertension. Increased RI and PI correlated with higher odds of hypertension (RI: adjusted OR 1.15 [95 % CI 1.03-1.30]; PI: adjusted OR 1.03 [95%CI 1.01-1.05] for each 0.1 unit increase). Maximum RI above 0.84 or maximum PI above 2.3 more than doubled the odds of incident hypertension (RI: adjusted OR 2.49, 95%CI 1.45-4.26; PI: adjusted OR 2.36, 95%CI 1.45-3.86).
CONCLUSION CONCLUSIONS
Higher resistance and pulsatility indices measured on second trimester UAD were associated with increased odds of incident hypertension 2-7 years later, and may be biomarkers of higher maternal cardiovascular risk.

Identifiants

pubmed: 35112117
doi: 10.1016/j.ijcrp.2021.200105
pii: S2772-4875(21)00007-6
pmc: PMC8790099
doi:

Types de publication

Journal Article

Langues

eng

Pagination

200105

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL136853
Pays : United States
Organisme : NHLBI NIH HHS
ID : L30 HL129418
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL153382
Pays : United States

Informations de copyright

© 2021 The Authors.

Références

J Am Heart Assoc. 2018 Jan 15;7(2):
pubmed: 29335319
J Am Heart Assoc. 2019 Oct;8(19):e013092
pubmed: 31564189
Am J Obstet Gynecol. 2017 Nov;217(5):594.e1-594.e10
pubmed: 28712949
BMJ Open. 2013 Aug 30;3(8):e003423
pubmed: 23996822
Thromb Res. 2016 Jan;137:126-140
pubmed: 26632513
Am J Epidemiol. 2016 Mar 15;183(6):519-30
pubmed: 26825925
J Vasc Res. 2014;51(4):290-304
pubmed: 25300258
Stroke. 2011 Feb;42(2):517-84
pubmed: 21127304
Stroke. 2014 May;45(5):1545-88
pubmed: 24503673
Semin Immunopathol. 2016 Nov;38(6):699-708
pubmed: 27339196
Am J Obstet Gynecol. 2009 Aug;201(2):121-6
pubmed: 19646563
Am J Obstet Gynecol. 2015 Apr;212(4):539.e1-539.e24
pubmed: 25648779
Am J Perinatol. 2013 Jun;30(6):505-12
pubmed: 23254384
Circulation. 2004 Jun 1;109(21 Suppl 1):II2-10
pubmed: 15173056
Obstet Gynecol. 2014 Oct;124(4):763-770
pubmed: 25198274
JAMA Neurol. 2014 Oct;71(10):1218-27
pubmed: 25090106
Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):
pubmed: 28228456
Am J Obstet Gynecol. 2019 Jan;220(1):96.e1-96.e8
pubmed: 30243605
Circulation. 2011 Jun 21;123(24):2856-69
pubmed: 21690502
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
Hypertension. 2016 Dec;68(6):e67-e94
pubmed: 27977393
Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):499-506
pubmed: 9988826
Ultrasound Obstet Gynecol. 2020 May;55(5):575-585
pubmed: 31785172
Am J Obstet Gynecol. 2020 Sep 21;:
pubmed: 32971013
Int J Epidemiol. 2012 Apr;41(2):514-20
pubmed: 22253321
Am J Obstet Gynecol. 2011 Mar;204(3):193-201
pubmed: 21094932
Obstet Gynecol. 1991 Mar;77(3):365-9
pubmed: 1992400
J Pathol. 2012 Nov;228(3):322-32
pubmed: 22653829
Circulation. 2017 Feb 7;135(6):578-589
pubmed: 28153993
Semin Perinatol. 2015 Feb;39(1):9-19
pubmed: 25511295
JAMA. 2019 Feb 12;321(6):553-561
pubmed: 30688979
J Am Heart Assoc. 2017 Jan 11;6(1):
pubmed: 28077386

Auteurs

Eliza C Miller (EC)

Department of Neurology, Division of Stroke and Cerebrovascular Disease, Columbia University Vagelos College of Physicians and Surgeons, USA.

Benjamin Carper (B)

RTI International, USA.

Natalie A Bello (NA)

Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, USA.

C Noel Bairey Merz (CN)

Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, USA.

Philip Greenland (P)

Department of Preventive Medicine and Division of Cardiology, Northwestern University, USA.

Lisa D Levine (LD)

Department of Obstetrics and Gynecology, University of Pennsylvania, USA.

David M Haas (DM)

Department of Obstetrics and Gynecology, Indiana University School of Medicine, USA.

William A Grobman (WA)

Department of Obstetrics and Gynecology, Northwestern University, USA.

Rebecca B McNeil (RB)

RTI International, USA.

Judith H Chung (JH)

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of California Irvine, USA.

Jennifer Jolley (J)

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of California Irvine, USA.

George R Saade (GR)

Department of Obstetrics and Gynecology, University of Texas Medical Branch, University of Texas, USA.

Robert M Silver (RM)

Department of Obstetrics and Gynecology, University of Utah and Intermountain Healthcare, USA.

Hyagriv N Simhan (HN)

Department of Obstetrics and Gynecology, University of Pittsburgh, USA.

Ronald J Wapner (RJ)

Department of Obstetrics and Gynecology, Columbia University, USA.

Corette B Parker (CB)

RTI International, USA.

Classifications MeSH